CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 9 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −97 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −14,858 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −142 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −10,216 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −97 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −10,447 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −99 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −4,971 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −47 | 0 | ||
| 2017-12-12 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2017-10-25 | Richman Michael Director | Grant or award · Stock Option (Rights to buy) | +4,006 | 4,006 | ||
| 2017-10-25 | Khuong Chau Quang Director | Grant or award · Stock Options (Right to buy) | +6,115 | 6,115 | ||
| 2017-08-17 | GERAGHTY JAMES A Director | Purchase | +10,000 | $4.82 | $48K | 10,000 |
| 2017-08-17 | Reine Allan See Remarks | Purchase | +20,000 | $4.89 | $98K | 65,000 |
| 2017-08-16 | Reine Allan See Remarks | Purchase | +45,000 | $4.79 | $216K | 45,000 |
| 2017-08-09 | Reine Allan See Remarks | Grant or award · Common Stock | +450,000 | 450,000 | ||
| 2017-07-25 | Khuong Chau Quang Director | Grant or award · Stock Option (right to buy) | +5,018 | 5,018 | ||
| 2017-07-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +3,288 | 3,288 | ||
| 2017-05-22 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2017-04-25 | Khuong Chau Quang Director | Grant or award · Stock Option (right to buy) | +10,546 | 10,546 |
Page 19 of 21 · 412 trades